Đức, L.T. and Lập, B.T. 2022. 15. Survival results of Gemcitabine-Carboplatin regimen chemotherapy of recurrent or metastatic in triple negative breast cancer. Journal of Medical Research. 156, 8 (Aug. 2022), 120-129. DOI:https://doi.org/10.52852/tcncyh.v156i8.1012.